Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Salbutamol dry-powder inhalation - Teva Pharmaceutical Industries

Drug Profile

Salbutamol dry-powder inhalation - Teva Pharmaceutical Industries

Alternative Names: ABS eMDPI; Airmax Salamol; Albuterol DPI - Teva; Albuterol dry-powder inhalation - Teva; Albuterol eMDPI; Albuterol MDPI; Albuterol Spiromax; Albuterol sulfate - Teva; Albuterol-dry-powder-inhalation; ProAir RespiClick; Salbutamol DPI - Teva

Latest Information Update: 20 Sep 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator IVAX Corporation
  • Developer Teva Pharmaceutical Industries
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma; Exercise-induced asthma
  • Registered Bronchospasm
  • Phase III Chronic obstructive pulmonary disease

Most Recent Events

  • 17 May 2019 Pharmacokinetics data from a phase III trial in Asthma presented at the 115th International Conference of the American Thoracic Society (ATS-2019)
  • 26 Dec 2018 Registered for Bronchospasm (Treatment, Prevention, In children, In adolescents, In adults, in patients with reversible obstructive airway disease) in USA (Inhalation; ProAir® Digihaler™)
  • 26 Dec 2018 Registered for exercise-induced Bronchospasm (Prevention, In children, In adolescents, In adults) in USA (Inhalation; ProAir® Digihaler™)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top